IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer
Publication year
2021Source
Oncology Letters, 22, 2, (2021), article 590ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Pathology
Internal Medicine
Radiation Oncology
Journal title
Oncology Letters
Volume
vol. 22
Issue
iss. 2
Subject
Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences; Internal Medicine - Radboud University Medical Center; Pathology - Radboud University Medical Center; Radboud University Medical Center; Radiation Oncology - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [242559]
- Faculty of Medical Sciences [92285]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.